Assessing the Quality of Life Using the Health Utilities Index Questionnaire in Children With Severe Persistent Asthma During the Treatment With Omalizumab

Background. Quality of life (QoL) is an important parameter that provides additional information about changes in health status. Objective. Our aim was to study the change in QoL of patients with severe persistent bronchial asthma (BA) during the treatment with genetically engineered biological prep...

Full description

Saved in:
Bibliographic Details
Main Authors: Leyla S. Namazova-Baranova, Elena A. Vishnеva, Elena A. Dobrynina, Irina V. Vinyarskaya, Anna A. Alekseeva, Vladislav V. Chernikov, Lilia R. Selimsianova
Format: Article
Language:Russian
Published: Union of pediatricians of Russia 2017-12-01
Series:Педиатрическая фармакология
Subjects:
Online Access:https://www.pedpharma.ru/jour/article/view/1558
Tags: Add Tag
No Tags, Be the first to tag this record!